文献速递乳腺MR

基于MRI深度学习框架的乳腺癌自动分割与分子亚型分类

Automatic Segmentation and Molecular Subtype Classification of Breast Cancer Using an MRI-based Deep Learning Framework.
PubMed 文献 · Radiol Imaging Cancer · 2025-01-01

这项回顾性多中心研究纳入687例经活检证实的浸润性乳腺癌女性患者,构建基于三维ResU-Net的自动病灶分割模型(内部测试集Dice 0.86,两个外部测试集0.82、0.85)和融合二维与三维特征的Ensemble ResNet分子亚型分类模型,三个测试集AUC分别为Luminal A 0.74-0.84、Luminal B 0.68-0.72、HER2富集型0.73-0.82、三阴性0.80-0.81。

要点

  • 自动分割模型在内部测试集Dice为0.86、两个外部测试集为0.82和0.85。
  • 四个分子亚型分割Dice为0.8571、0.8323、0.8199、0.8481。
  • Ensemble ResNet在三测试集AUC:Luminal A 0.74-0.84,三阴性0.80-0.81。

核心结论

  • 基于MRI的新型深度学习框架在乳腺癌分子亚型全自动分类中表现出高且稳健的性能。

研究设计与样本

  • 回顾性多中心研究,纳入2015年1月至2021年1月间经活检证实的浸润性乳腺癌女性患者687例(平均年龄48.70岁±8.97),其中训练集289例、内部测试集61例、两个外部测试集分别为73例和264例;分割模型以三维ResU-Net为骨干,分类模型Ensemble ResNet融合二维与三维病灶特征。

诊断标准与关键数值

  • 分割模型在内部测试集1、外部测试集2、外部测试集3的Dice分别为0.86、0.82、0.85;按亚型Luminal A、Luminal B、HER2富集型、三阴性的Dice分别为0.8571、0.8323、0.8199、0.8481;Ensemble ResNet在三个测试集预测Luminal A的AUC范围0.74-0.84、Luminal B为0.68-0.72、HER2富集型为0.73-0.82、三阴性为0.80-0.81。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

Purpose To build a deep learning framework using contrast-enhanced MRI for lesion segmentation and automatic molecular subtype classification in breast cancer. Materials and Methods This retrospective multicenter study included patients with biopsy-proven invasive breast cancer between January 2015 and January 2021. An automatic breast lesion segmentation model was developed using three-dimensional (3D) ResU-Net as the backbone, and its accuracy was evaluated in an internal and two external testing datasets using the Dice score. An ensemble model for classification of breast cancer into four molecular subtypes (Ensemble ResNet) was then developed by combining both two-dimensional and 3D lesion features. The performance of Ensemble ResNet was evaluated in the three testing datasets using the area under the receiver operating characteristic curve (AUC). Results A total of 687 female patients (mean age ± SD, 48.70 years ± 8.97) were included, with 289, 61, 73, and 264 patients included in the training, internal testing, and two external testing datasets, respectively. The proposed segmentation model achieved high accuracy in internal testing dataset 1, external testing dataset 2, and external testing dataset 3 (Dice scores: 0.86, 0.82, 0.85) and luminal A, luminal B, human epidermal growth factor receptor 2 (HER2)-enriched, and triple-negative breast cancer (TNBC) subtypes (Dice scores: 0.8571, 0.8323, 0.8199, 0.8481). Ensemble ResNet demonstrated high performance for the prediction of luminal A subtypes (AUC range, 0.74-0.84), luminal B subtypes (AUC range, 0.68-0.72), HER2-enriched subtypes (AUC range, 0.73-0.82), and TNBC (AUC range, 0.80-0.81) in the three testing datasets. Conclusion The proposed novel deep learning framework based on MRI achieved high, robust performance in fully automatic classification of breast cancer molecular subtypes. Keywords: MR-Imaging, Breast, Oncology, Breast Cancer, Molecular Subtype, Deep Learning Framework Supplemental material is available for this article. © RSNA, 2025.

来源:Radiol Imaging Cancer,查看原文。版权归原作者所有。

引用

  1. Wang X, Hu X, Wang C, et al. Automatic Segmentation and Molecular Subtype Classification of Breast Cancer Using an MRI-based Deep Learning Framework. Radiol Imaging Cancer. 2025. PMID: 40249269. doi:10.1148/rycan.240184

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。